Prital Desai, MD
Psychiatry · Santa Rosa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 1 carrier
- Office
- 1
- Since medical school
- 21 years
- Graduated 2005
Offices
1 location · Mark David Levine MD Professional Corporation · 165 clinicians in this group
Plans that list them
14 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Desai’s office at (855) 601-1004 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A150768 · Current
Licensed to practise in California · since 2017 · expires 2027-08-31 · Gujarat University, B. J. Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Child and Adolescent Psychiatry
Medicaid work
$9,942 in 2024
Medicaid paid $9,942 for 36 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 36 | $9,942 |
| 2024 | 36 | 1 | 17 | $9,942 |
| 2023 | 112 | 1 | 18 | $30,150 |
| 2022 | 137 | 1 | 20 | $32,051 |
| 2021 | 105 | 2 | 15 | $19,098 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 112 | $30,150 |
2022
| Return visit (30+ min) | 137 | $32,051 |
2021
| Return visit (30+ min) | 88 | $15,759 |
| Psychiatric diagnostic evaluation with medical services | 17 | $3,339 |
Drugs they prescribed that Part D paid
$1,979
Pharmacies billed $1,979 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 117) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
117 generic and 0 brand-name prescriptions · $1,979 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Olanzapine | 12 | $457 | $38 |
Year by year
| 2024 | 117 | 12 | 0% (0) | 0% | $1,979 |
| 2023 | 48 | None | 0% (0) | 0% | $914 |
| 2022 | 27 | None | 0% (0) | 0% | $784 |
| 2021 | 62 | 17 | None | None | $5,241 |
| 2020 | 269 | 24 | 0% (0) | 0% | $6,918 |
| 2019 | 325 | 33 | 0% (0) | None | $8,240 |
| 2018 | 121 | 21 | 0% (0) | None | $3,241 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 1 drug
| Bupropion Xl | 18 | $389 | $22 |
2020: 9 drugs
| Bupropion Xl | 42 | $1,612 | $38 |
| Quetiapine | 30 | $859 | $29 |
| Duloxetine | 25 | $603 | $24 |
| Lamotrigine | 16 | $483 | $30 |
| Fluoxetine | 13 | $385 | $30 |
| Mirtazapine | 15 | $320 | $21 |
| Trazodone | 27 | $279 | $10 |
| Clonazepam | 14 | $101 | $7 |
| Alprazolam | 12 | $17 | $1 |
2019: 12 drugs
| Bupropion Xl | 25 | $1,301 | $52 |
| Quetiapine | 35 | $595 | $17 |
| Mirtazapine | 21 | $399 | $19 |
| Escitalopram | 23 | $372 | $16 |
| Duloxetine | 18 | $341 | $19 |
| Lamotrigine | 20 | $289 | $14 |
| Trazodone | 24 | $286 | $12 |
| Fluoxetine | 11 | $265 | $24 |
| Lorazepam | 11 | $261 | $24 |
| Alprazolam | 12 | $108 | $9 |
| Clonazepam | 20 | $102 | $5 |
| Chlordiazepoxide | 18 | $89 | $5 |
2018: 2 drugs
| Mirtazapine | 18 | $603 | $33 |
| Quetiapine | 13 | $151 | $12 |
Money from drug and device companies
$41 in 2020
| 2020 | 3 | 3 | None | $41 |
| 2019 | 5 | 6 | None | $113 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Takeda Pharmaceuticals U.S.A. | Vyvanse | $15 | 1 payment
|
| Janssen Pharmaceuticals | Spravato | $14 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $12 | 1 payment
|
See all 3 published payments
| Neurocrine Biosciences | Meals · 2020-03-04 | Ingrezza | $12 |
| Janssen Pharmaceuticals | Meals · 2020-02-26 | Spravato | $14 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2020-01-29 | Vyvanse | $15 |
See earlier years (2019)
2019: $113
| Neurocrine Biosciences | Ingrezza | $38 | 2 payments
|
| Sunovion Pharmaceuticals | Latuda | $22 | 1 payment
|
| Janssen Pharmaceuticals | Spravato | $18 | 1 payment
|
| Lundbeck | Rexulti | $18 | 1 payment
|
| Jazz Pharmaceuticals | Xyrem | $18 | 1 payment
|
Professional record
- NPI
- 1801224092
- Licence
- CA A150768, CA A150769California A150768: Current · expires 2027-08-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 480 Tesconi Cir Ste B, Santa Rosa, CA, 95401
- NPI first listed
- 2013-10-24
- NPI last updated
- 2020-10-20
- NPI record certified
- 2020-10-20
This is when the NPI record was last certified, not a medical board exam.